60 Degrees Pharmaceuticals, Inc. (SXTP)

1.08 0.00 (0.00%) USD  |  NASDAQ  |  Aug 25, 15:41
More

60 Degrees Pharmaceuticals Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for SXTP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
August 17, 2026 --
May 22, 2026 --
May 20, 2026 --
March 31, 2026 --
January 27, 2026 --
November 27, 2025 --
November 14, 2025 --
September 03, 2025 --
June 02, 2025 --
May 16, 2025 --
April 07, 2025 --
March 28, 2025 --
February 25, 2025 --
Date Value
November 23, 2024 --
November 15, 2024 --
August 20, 2024 --
August 15, 2024 --
May 16, 2024 --
April 08, 2024 --
April 03, 2024 --
February 02, 2024 --
December 11, 2023 --
November 21, 2023 --
October 20, 2023 --
October 14, 2023 --
October 02, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Harrow, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade
Johnson & Johnson Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade